期刊文献+

应用载体构建小干扰RNA对小鼠葡聚糖硫酸钠结肠炎的影响

原文传递
导出
摘要 溃疡性结肠炎(ulcerativc colitis,UC)的病因和发病机制尚不清楚,治疗仍是临床上的一大难题。传统药物疗效欠佳,不良反应大。有研究显示,UC发病与肿瘤坏死因子(TNF)-α关系密切,使用抗TNF-α抗体有治疗作用,但维持时间短。RNA干扰(RNAi)技术有高度的特异性和有效性,不仅能抑制外源性基因而且能特异性沉默内源性基因表达¥为抗炎、抗凋亡、抗肿瘤提供了新的思路和方法。本研究将RNAi进一步运用于葡聚糖硫酸钠(DSS)诱导的小鼠结肠炎模型上,探讨其治疗作用,以寻找治疗UC的新途径。
出处 《中华消化杂志》 CAS CSCD 北大核心 2008年第7期492-494,共3页 Chinese Journal of Digestion
  • 相关文献

参考文献9

  • 1Jarnerot G, Hertervig E, Friis-Liby l, et al. Infliximah as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology, 2005, 128:1805-1811.
  • 2Elbashir SM, Harbort J, Lendackel W, et al. Duplexes of 21- nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 2001,411 : 494-498.
  • 3谭兵,李瑜元,聂玉强,杜艳蕾.应用载体介导小干扰RNA抑制小鼠巨噬细胞表达肿瘤坏死因子α[J].中华消化杂志,2008,28(4):250-253. 被引量:1
  • 4Cooper HS, Murthy SN, Rupal RS, et al. Clinicopathologic study of dextran sulfate sodium experimental routine colitis. Lab Invest,1993, 69:238-249.
  • 5Zhang G, Budker V, Wolff JA. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther, 1999, 10:1735-1737.
  • 6Murano M,Maemura K, Hirata I, et al. Therapeutic effect of intracolonieally administered nuclear factor kappa B (P65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS) - induced colitis. Clin Exp Immunol, 2000,120 : 51-58.
  • 7Dieleman LA, Palmen M, Akol H, et al. Chronic experimental colitis induced by dextran sulphate sodium(DSS) is characterized by Thl and Th2 cytokines. Clin Exp Immunol, 1998,114:385-391.
  • 8Sorensen DR, Lemdal M, Srnnd M. Gene silencing by Systemie delivery of synthetie siRNAs in adult miee. J Mol Biol, 2003,327: 761-766.
  • 9谭兵,李瑜元,聂玉强,杜艳蕾.RNA干扰对活化的小鼠巨噬细胞肿瘤坏死因子α表达的影响[J].中华医学杂志,2007,87(30):2140-2143. 被引量:2

二级参考文献25

  • 1Shlomai A, Shaul Y. Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology, 2003, 37: 764-770.
  • 2Nieth C, Priebsch A, Stege A, et al. Modulation of the classical multi-drug resistance (MDR) phenotype by RNA interference (RNAi). FEBS Lett, 2003, 545: 144-150.
  • 3Sorensen DR, Leirdal M, Sioud M. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol, 2003, 327 : 761-766.
  • 4Pisetsky DS. Tumor necrosis factor alpha blockers and the induction of anti-DNA autoantibodies. Arthrites Rheum, 2000,43: 2381-2382.
  • 5Targan SR, Hanauer SB, van Deventer SJ, et al. A shortterm study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. N Engl J Med, 1997,337: 1029-1035.
  • 6Sands BE, Tremaine WJ, Sandborn WJ, et al. Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis, 2001,7: 83-88.
  • 7Mease PJ, Goffe BS, Metz J, et al. Etanercept in the treatment of psoriatic arthritis and psoriasis; a randomized trial.Lancet,2000,356: 385-390.
  • 8Gorman JD, Sack KE, Davis JC Jr. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor α. N Engl J Med,2002,346 : 1349-1356.
  • 9Hutvagner G. Small RNA asymmetry in RNAi: function in RISC assembly and gene regulation. FEBS Lett, 2005, 579: 5850-5857.
  • 10Meister G, Tuschl T. Mechanisms of gene silencing by double stranded RNA. Nature, 2004,431: 343-349.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部